Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

Elie A Akl, Maddalena Barba, Sandeep Rohilla, Irene Terrenato, Francesca Sperati, Paola Muti, Holger J Schünemann
  • Journal of Experimental & Clinical Cancer Research, July 2008, Springer Science + Business Media
  • DOI: 10.1186/1756-9966-27-21

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Elie A Akl

In partnership with: